Skip to main content
. 2019 Sep 25;45(8):726–738. doi: 10.1007/s00059-019-04850-w

Table 2.

Results of the meta-analysis comparing OSAS patients and controls

Echocardiographic parameters Number of studies OSAS/control WMD (95%CI) p Study heterogeneity Egger’s test p Begg’s test p
I 2 (%) χ2 p
LVEDD (mm) 13 563/319 1.24 (0.68, 1.80) <0.001 0.0 9.52 0.658 0.431 0.951
LVESD (mm) 11 396/234 1.14 (0.47, 1.81) 0.001 0.0 7.31 0.696 0.722 1.00
LVM 6 304/128 35.34 (20.67, 50.00) <0.001 79.1 66.05 <0.001 0.914 0.917
LVEF (%) 15 710/394 −3.01 (−1.90, −0.79) 0.001 64.7 39.72 <0.001 0.048 0.038
LAD 7 311/157 2.13 (1.48, 2.77) <0.001 2.2 6.13 0.408 0.072 0.05
LAVI 3 159/69 3.96 (3.32, 4.61) <0.001 0.0 1.62 0.445 0.735 1.000

OSAS obstructive sleep apnea syndrome, LVEDD left ventricular diastolic diameter, LVESD left ventricular systolic diameter, LVM left ventricular mass, LVMI left ventricular mass index, LVEF LV ejection fraction, E early diastolic peak flow velocity, A late diastolic peak flow velocity, CI confidence interval